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INTRODUCTION: 
Emtricitabine and Tenofovir  are antiretroviral drugs 
used for the treatment of HIV1. Forstavir - EM is the 
combination of the two drugs containing 200mg of EMB 
and 300mg of TEN. Emtricitabine is chemically 4-
Amino-5-fluoro-1-[2-(hydroxymethyl)-1, 3-oxathiolan-
5-yl]-pyrimidin-2-one2,3.It is a nucleoside reverse 
transcriptase inhibitor. The structure of EMB is given in 
Figure 1. 
 
Figure 1: Chemical structure of EMB 
 
Chemically Tenofovir is 1-(6-Aminopurin-9-yl)-prapan-
2-yl-oxymethylphosphonic acid4. It is a nucleotide 
analogue reverse transcriptase inhibitor. The structure of 
TEN is given in Figure 2.  
 
Figure 2: Chemical structure of TEN 
Extensive literature survey revealed that only LC-
MS/MS5and RP-HPLC6 methods for the determination of 
EMB and TEN in human plasma, RP-HPLC7 for 
determination of TEN in plasma, LC/MS/MS for 
determination of plasma TEN concentrations8, LC-MS 
method for determination of plasma TEN concentrations9 
and HPLC with fluorimetric detection for determination 
of EMB in human plasma10 have been reported so 
far.However, to the best of our knowledge, no first 
derivative spectrophotometric method is published for 
the simultaneous determination of EMB and TEN in 
tablet dosage form. The present work describes the 
development of a simple, precise, accurate, and 
reproducible spectrophotometric method for the 
simultaneous estimation of EMB and TEN in combined 
dosage form. The developed method was validated in 
accordance with ICH guideline and successfully 
employed for the assay of EMB and TEN in combined 
tablet dosage form. 
MATERIALS AND METHODS: 
Chemicals and Reagents 
Working standards of EMB and TEN were provided as 
gift samples by Ranbaxy Laboratories, India. Forstavir - 
EM tablets were purchased from a local pharmacy. 
Instruments 
Shimadzu UV-Vis Spectrophotometer-1650, 1 cm 
matched quartz cells, and UV probe 2.34 software was 
used. Calibrated analytical balance Shimadzu BP211D 
(Sartorius Gottingen AG, Germany) was used for 
weighing purpose. All statistical calculations were 
carried out using Microsoft Excel 2007 analytical tool. 
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A simple, precise, accurate, and economical spectrophotometric method has been developed for simultaneous estimation of 
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Preparation of Standard Stock Solutions 
Accurately weighed 25 mg of EMB and TEN standards 
was transferred to a separate 25 mL volumetric flask and 
dissolved in 10 mL distilled water. The flasks were 
shaken and volume was made up to the mark with 
distilled water. These solutions are 1000 µg/mL EMB 
and 1000 µg/mL TEN respectively. 
 Selection of Analytical Wavelength 
Working standard solutions of 6-16 μg/mL of EMB and 
9-24 μg/mL of TEN were prepared in distilled water by 
appropriate dilution, and the spectrum was recorded 
between 200 and 400 nm, and all zero-order spectrums 
(D0) were converted to first derivative spectrums (D1). 
The overlain first derivative spectrums of LCT and PHE 
at different concentrations were recorded.  
Method Validation
11 
The proposed method was validated in terms of linearity, 
accuracy, precision, limits of detection (LOD) and 
quantification (LOQ) and reproducibility.  
Linearity 
Appropriate aiquots from EMB and TEN standard stock 
solution were transferred to volumetric flasks of 10 mL 
capacity. The volume was adjusted to the mark with 
distilled water to give working standard solutions 
containing 6-16 μg/mL for EMB and 9-24 μg/mL for 
TEN respectively. All D1 spectra were recorded using the 
above spectrophotometric condition. D1 absorbance at 
257 nm and 282 nm was recorded for EMB and TEN, 
respectively. Calibration curves were constructed by 
plotting average absorbance versus concentrations for 
both drugs. Straight line equations were obtained from 
these calibration curves. 
Accuracy 
Accuracy was assessed by the determination of the 
recovery of the method by addition of standard drug to 
the prequantified sample preparation. Each concentration 
was analyzed 3 times, and average recoveries were 
measured. 
Precision 
The repeatability was evaluated by assaying 6 times the 
sample solution prepared for assay determination. The 
results are reported in terms of % RSD. 
Detection Limit and Quantitation Limit 
In the present study, the LOD and LOQ were  calculated  
by the use of standard deviation of the response and the 
slope of the calibration curve.  
Reproducibility 
The absorbance readings were measured in a different 
laboratory, using another spectrophotometer by another 
analyst, and the values obtained were evaluated to verify 
their reproducibility. 
Determination of EMB and TEN in Their Combined 
Tablet Dosage Form 
Twenty tablets were weighed and crushed to a fine 
powder. An accurately weighed powder equivalent to 
300mg of TEN and 200mg of EMB was transferred to a 
100mL volumetric flask and dissolved in about 75mL of 
methanol. The volume was then made upto the mark 
with methanol. The solution was sonicated for about 15 
minutes and filtered through Whatmann filter 
paper(0.45 μ) and diluted to prepare the concentration of 
9-24µg/mL TEN and 6-16µg/mL of EMB. The resulting 
solution was analyzed by the proposed method. The 
quantitation was carried out by keeping these values to 
the straight line equation of the calibration curve. 
RESULTS AND DISCUSSION: 
First-order derivative spectrophotometric method was 
developed for determination of EMB and TEN. 
Figure 3 shows overlain D1 spectra of EMB and TEN at 
different concentrations. 
 
Figure 3: Overlain D
1
 spectra of EMB and TEN 
 
The optical characteristics such as absorption maxima, 
Beer’s law limits and the regression characteristics like 
slope(b),intercept(c), correlation co-efficient(r), percent 
relative standard deviation(% RSD) and standard 
error(SE) were calculated and the results are summarized 
in Table-1. The results of sample analysis showed that 
the drug determined by the proposed methods was in 
good agreement with the label claim proving the 
accuracy of the proposed methods. 
To study the accuracy and reproducibility of the 
proposed methods, recovery experiments were carried 
out by adding a known amount of drug to preanalysed 
sample and the percentage recovery was calculated. The 
results are furnished in Table-2. The results indicate that 
there is no interference of other ingredients present in the 
formulations. Thus, the proposed method is simple, 
sensitive, economical, accurate and reproducible and 
useful for the simultaneous estimation of EMB and TEN 
in combined tablet dosage form. 
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Table 1: Optical and Statistical parameters 
 
 
 
 
 
 
 
 
 
   
 
Table 2: Assay and recovery of EMB and TEN 
Method Labelled amount(mg) Amount obtained(mg)* Percentage recovery** 
EMB 200 199.75 99.99% 
TEN 300 299.45 100.43% 
*Average of six determinations                        **Average of three determinations 
 
CONCLUSIONS: 
The proposed first-order derivative method provides 
simple, specific, precise, and accurate quantitative 
analysis for simultaneous determination of EMB and 
TEN in combined tablet dosage form. The method was 
validated as per ICH guidelines in terms of linearity, 
accuracy, precision, limits of detection (LOD) and 
quantification (LOQ) and reproducibility. The proposed 
method can be used for routine analysis of EMB and 
TEN in combined dosage form. 
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Parameters EMB TEN 
Absorption maximum/ 
Wavelength range(nm) 
200-400 200-400 
Linearity Range(µg/mL) 6-16 9-24 
Correlation coefficient 0.9994 0.9992 
% RSD 0.0460 0.0307 
Standard Error(SE) 0.0424 0.0122 
Regression Equation 
y=mx+c 
0.9089x+0
.1414 
0.5065x+0.1
223 
Intercept (c) 0.1414 0.1223 
Slope (m) 0.9089 0.5065 
LOD(µg/mL) 0.1180 0.1212 
LOQ(µg/mL) 0.3601 0.3672 
